Ona Therapeutics received an exclusive global license for the WuXiTecan-2 payload-linker technology platform, along with comprehensive CMC support.
1 report, 1 independent
Updated Sep 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ona Therapeutics received an exclusive global license for the WuXiTecan-2 payload-linker technology platform, along with comprehensive CMC support.